From: LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
Cancer type | Prognostic indicator | Associated clinical features | Ref. |
---|---|---|---|
Bladder cancer | OS | tumor stage, histological grade, lymph node metastasis | |
Cervical cancer | OS | tumor size, tumor differentiation, lymph node metastasis, FIGO stage | |
Colorectal Cancer | OS | – | [32] |
Endometrial carcinoma | OS, recurrence free survival | – | [34] |
Esophageal squamous cell carcinoma | OS | tumor stage, clinical stage, lymph nodes metastasis | [36] |
Gastric Cancer | OS | tumor size, tumor differentiation, TNM stage, lymph node metastasis | |
Glioma | OS, PFS | tumor size, WHO grade | [41] |
Hepatocellular carcinoma | OS, PFS | tumor size, TNM stage | |
Neuroblastoma | OS, event free survival | – | |
Non small cell lung cancer | OS, DFS | tumor size, TNM stage, lymph node metastasis | [53] |
Osteosarcoma | OS | – | |
Ovarian cancer | OS | clinical stage, distance metastasis | [60] |
Pancreatic cancer | OS | TNM stage, tumor differentiation, distant metastasis | [61] |